Table 1.

Demographic and clinical feature at the time of presentation of children with bacteremia from ESBL group and non ESBL group E. coli or Klebsiella spp.

	Non-ESBL (n=45)	ESBL (n=52)	P-value
Sex (M:F)	26:19	27:25	0.334
Mean ± SD of age (month)	65 ± 81	69 ± 75	0.708
Mean ± SD of length of stay	37 ± 57	93 ± 180	0.083
Day	25	40	< 0.01
Underlying disease
Hematological malignancy	8	15	0.463
Solid tumor	2	2	0.661
Nephrotic syndrome	2	3	1
Congenital heart disease	1	12	< 0.01
End stage renal disease	3	3	0.661
SLE	0	2	0.497
Preterm	7	0	< 0.01
Newborn	2	1	0.595
Chronic lung disease	0	2	0.497
Neurological problem	4	4	0.729
Focal infection
Pneumonia	10	21	0.17
Urinary tract infection	13	14	0.58
Diarrhea	1	5	0.18
Cellulitis	1	3	0.54
Ascending cholangitis	2	0	0.15
Meningitis	2	2	0.72
Mortality (%)	6 (13.3%)	20 (38.9%)	< 0.05

ESBL group: patient with bacteremia caused by ESBL producing—E. coli or Klebsiella spp.

Non-ESBL group: patient with bacteremia caused by non-ESBL producing—E. coli or Klebsiella spp.